BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3613072)

  • 1. [Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
    Uno N; Nosaka T; Uchiyama S; Kawakami K; Hoshino K; Mori M; Hotta Y; Ohta C; Kobayashi T; Kita K
    Jpn J Antibiot; 1987 Mar; 40(3):469-75. PubMed ID: 3613072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections].
    Sakashita S; Shinno Y; Asano Y; Tubo S; Imanaka K; Miyabe N; Nagamori S; Takahashi Y; Koyanagi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1547-50. PubMed ID: 3565192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
    Yamaguchi H; Ichimaru M
    Jpn J Antibiot; 1980 Nov; 33(11):1215-22. PubMed ID: 7241796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of cefoxitin on infections secondary to hematopoietic malignancies].
    Sawada H; Ishikura H; Izumi Y; Usui T; Konishi H; Uchino H
    Jpn J Antibiot; 1982 Jun; 35(6):1610-4. PubMed ID: 7131771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
    Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
    Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
    Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined action of cephamycin and aminoglycoside antibiotics].
    Tanaka M; Kawabata S; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2869-80. PubMed ID: 6674522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders].
    Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T
    Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M; Hirashima K
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of cefoxitin in the field of internal medicine].
    Ito A; Shindo K; Sakamoto H; Sano F; Ishigatsubo Y; Matsumura M; Tani K; Maruta I; Kodama F; Fukushima K
    Jpn J Antibiot; 1983 Jan; 36(1):84-92. PubMed ID: 6842829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with cefoxitin in infections associated with hematopoietic disorders].
    Minami N; Uno N; Katayama N; Kataoka Y; Kamio N; Iwata Y; Tanaka I; Karitani Y; Shirakawa S
    Jpn J Antibiot; 1983 Oct; 36(10):2881-6. PubMed ID: 6674523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.
    Tally FP; McGowan K; Kellum JM; Gorbach SL; O'Donnell TF
    Ann Surg; 1981 Mar; 193(3):318-23. PubMed ID: 7011222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
    Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
    Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    Hasegawa S; Nakao I
    Jpn J Antibiot; 1984 Sep; 37(9):1631-6. PubMed ID: 6512982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of cefoxitin on infections in digestive diseases].
    Irie T; Sakai H; Mae S
    Jpn J Antibiot; 1985 Jan; 38(1):74-82. PubMed ID: 3989980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience of cefoxitin in the treatment of infections complicated by intractable blood disorders].
    Utsumi M; Hotta T; Shimizu K; Kato T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1982 Dec; 35(12):2755-9. PubMed ID: 7182530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.